The Arab Drug Company (EGX:ADCI)

Market Cap	3.35B +119.3%
Revenue (ttm)	1.33B +29.3%
Net Income	229.10M +40.3%
EPS	19.09 +44.3%
Shares Out	12.00M
PE Ratio	14.62
Forward PE	n/a
Dividend	4.17 (1.49%)
Ex-Dividend Date	Oct 28, 2025

Volume	23,649
Open	279.20
Previous Close	279.20
Day's Range	274.00 - 287.90
52-Week Range	126.00 - 325.00
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 1,148
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ADCI

Financial Performance

In fiscal year 2025, The Arab Drug Company's revenue was 1.12 billion, an increase of 42.35% compared to the previous year's 785.52 million. Earnings were 198.93 million, an increase of 125.18%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 5, 2026

Data Sources Report a data error